Table 1.
Characteristics of patients undergoing IVF/ICSI.
| Characteristics | EMS group | Control group | p1 | OMA group | Peritoneal EMS group | p2 | Cystectomy group | Aspiration group | p3 |
|---|---|---|---|---|---|---|---|---|---|
| No. of patients | 459 | 360 | 363 | 96 | 224 | 139 | |||
| Age (y), mean ± SD | 31.46 ± 3.53 | 31.84 ± 3.8 | 0.259 | 31.43 ± 3.57 | 31.6 ± 3.36 | 0.662 | 31.76 ± 3.29 | 32.50 ± 3.75 | 0.055 |
| BMI (kg/m2), mean ± SD | 21.39 ± 1.74 | 21.19 ± 1.80 | 0.114 | 20.92 ± 2.29 | 20.74 ± 1.79 | 0.495 | 21.05 ± 1.75 | 20.70 ± 2.96 | 0.214 |
| Duration of infertility (y), mean ± SD | 2.99 ± 2.35 | 2.92 ± 3.00 | 0.706 | 2.78 ± 2.15 | 3.79 ± 2.87 | 0.002 | 10.98 ± 6.00 | 10.71 ± 2.21 | 0.617 |
| Primary infertility, n (%) | 303 (66.0) | 123 (34.2) | 0.000 | 248 (68.3) | 55 (57.3) | 0.042 | 151 (67.4) | 73 (52.5) | 0.637 |
| Day 3, mean ± SD | |||||||||
| FSH (IU/L) | 6.95 ± 8.47 | 6.17 ± 2.28 | 0.404 | 7.17 ± 9.42 | 6.07 ± 2.21 | 0.263 | 7.83 ± 11.78 | 6.12 ± 2.62 | 0.038 |
| LH (IU/L) | 3.95 ± 4.59 | 3.67 ± 1.63 | 0.554 | 3.99 ± 4.80 | 3.81 ± 3.66 | 0.731 | 4.25 ± 5.98 | 3.59 ± 1.65 | 0.209 |
| E2 (pg/mL) | 39.46 ± 34.37 | 33.79 ± 37.85 | 0.026 | 40.09 ± 34.11 | 37.04 ± 35.41 | 0.447 | 42.74 ± 40.13 | 35.82 ± 20.49 | 0.062 |
| AFC, mean ± SD | 8.00 ± 5.91 | 10.25 ± 5.64 | 0.000 | 7.65 ± 5.33 | 9.35 ± 7.61 | 0.041 | 7.25 ± 5.20 | 8.29 ± 5.50 | 0.068 |
| hMG and MPA duration (d), mean ± SD | 10.84 ± 4.51 | 10.75 ± 1.93 | 0.699 | 10.88 ± 4.90 | 10.72 ± 2.53 | 0.762 | 10.98 ± 6.00 | 10.71 ± 2.21 | 0.617 |
| hMG dose (IU), mean ± SD | 1,567 ± 652 | 1,629 ± 580 | 0.151 | 1,545 ± 668 | 1,645 ± 586 | 0.149 | 1,505 ± 694 | 1,612 ± 619 | 0.127 |
| MPA dose (mg), mean ± SD | 54 ± 45 | 51 ± 43 | 0.351 | 54 ± 46 | 54 ± 44 | 0.962 | 56 ± 49 | 50 ± 39 | 0.161 |
p1, EMS group vs. control group; p2, Ovarian EMS group vs. peritoneal EMS group; p3, cystectomy group vs. aspiration group; BMI, body mass index; FSH, follicle-stimulating hormone; LH, luteinizing hormone; E2,estrogen; AFC, antral follicle count; hMG, human menopausal gonadotropin; MPA, medroxyprogesterone acetate. The red number highlights the p which was less than 0.05 signifing the statistic difference.